首页 | 本学科首页   官方微博 | 高级检索  
检索        

白细胞介素-18干预诱导的树突状细胞表型和活性研究
引用本文:傅永强,张在云,李旭升,柳月安.白细胞介素-18干预诱导的树突状细胞表型和活性研究[J].中国病理生理杂志,2008,24(7):1414-1417.
作者姓名:傅永强  张在云  李旭升  柳月安
作者单位:1金华职业技术学院医学院,浙江 金华 321017;2山东大学第二医院肿瘤科,3山东省肿瘤医院药剂科,山东 济南 250033
基金项目:金华市科技创新重点项目
摘    要:目的:研究白细胞介素-18(IL-18)干预诱导的树突状细胞(DC)的表型和活性。方法:自人外周血单核细胞诱导DC,第5 d起分为IL-18组、TNF-α组和IL-18+TNF-α组,分别加IL-18、TNF-α及IL-18+TNF-α促成熟,用ELISA法测定上清中IL-12含量;用流式细胞仪测定培养8 d DC的CD1a、HLA-DR、CD83及CD86的表达;用MTT法检测3组DC诱导T细胞增殖的作用。用ELISA法测定3组DC刺激T细胞分泌干扰素γ(IFN-γ)的量。结果:IL-18组与TNF-α组CD1a、HLA-DR、CD83及CD86表达无差异,IL-18+TNF-α组CD1a、CD83及HLA-DR阳性率高于IL-18组。IL-18+TNF-α组IL-12量高于IL-18组和TNF-α组(P<0.05)。IL-18组与TNF-α组DC刺激T细胞增殖作用无差异,IL-18+TNF-α组DC的作用强于IL-18组和TNF-α组。IL-18组和TNF-α组IFN-γ量无显著差异,IL-18+TNF-α组IFN-γ的量高于IL-18组和TNF-α组(P<0.05)。结论:IL-18干预诱导的DC高表达表面分子,具有明显的免疫刺激活性,IL-18与 TNF-α合用作用更强。

关 键 词:白细胞介素18  树突细胞  干预性研究  
收稿时间:2007-3-14
修稿时间:2007-11-19

Phenotype and immune activity of dendritic cells under interleukin-18 intervention
FU Yong-qiang,ZHANG Zai-yun,LI Xu-sheng,LIU Yue-an.Phenotype and immune activity of dendritic cells under interleukin-18 intervention[J].Chinese Journal of Pathophysiology,2008,24(7):1414-1417.
Authors:FU Yong-qiang  ZHANG Zai-yun  LI Xu-sheng  LIU Yue-an
Institution:1Medical College of Jinhua Vocational and Technical University, Jinhua 321017, China; 2Department of Oncology, The Second Hospital of Shandong University, 3Department of Pharmacy, Shandong Tumour Hospital, Jinan 250033, China.E-mail: fyq666166@126.com
Abstract:AIM: To investigate the phenotype and immune activity of dendritic cells using interleukin-18 as intervent.METHODS: Monocytes were isolated from human peripheral blood and induced into DCs with GM-CSF and IL-4. The cellular morphous was observed under inverted microscope. On the 5th day, 3 groups including IL-18 group, TNF-α group and IL-18+TNF-α group were set. IL-18, TNF-α or IL-18+TNF-α was used as intervents respectively to facilitate cell maturity. Supernatants were collected at 24 h, 48 h and 72 h. IL-12 in the supernatant, CD1a, HLA-DR, CD83 and CD86 were analyzed using flow cytometry. DCs of the 3 groups were co-cultured with T cells respectively on the ratio of 1∶〖KG-*2〗100, 1∶〖KG-*2〗50 and 1∶〖KG-*2〗10. T cell proliferation stimulated by DC was determined using MTT method. DCs were co-cultured with T cells on the ratio of 1∶〖KG-*2〗10, and the supernatant were collected at 24 h, 48 h and 72 h. IFN-γ in the supernatant was detected with ELISA method.RESULTS: Induced by GM-CSF and IL-4, then stimulated by IL-18, TNF-α or IL-18+TNF-α, monocytes showed typical morphous of DC. No morphological difference was observed among DCs of the 3 groups. No statistical difference showed in expression level of CD1a, HLA-DR, CD83 and CD86 between IL-18 group and TNF-α group (P>0.05). The positive rates of CD1a and CD83 in IL-18+TNF-α group were higher than those in other 2 groups. The positive rate of HLA-DR in IL-18+TNF-α group was higher than that in IL-18 group. No difference between IL-18 group and TNF-α group in the potency of stimulating T cell proliferation was found, whereas the stimulating potency in IL-18+TNF-α group was higher than that in IL-18 group and TNF-α group. IL-12 in IL-18+TNF-α group at 48 h and 72 h was higher than that in IL-18 group and TNF-α group (P<0.05). However, there was no difference between the latter 2 groups. There was also no difference between IL-18 group and TNF-α group in IFN-γ secretion. IFN-γ in IL-18+TNF-α group was higher than that in IL-18 group and TNF-α group (P<0.05).CONCLUSION: Using IL-18 as intervent, DC expresses high level of surface molecules, secretes high level of IL-12, stimulates T cell proliferating effectively and produces IFN-γ potently. The actions are stronger when used in combination with TNF-α. It suggests that IL-18 may serve as a promoting agent of DC maturity, or combination with TNF-α in DC induction will strengthen the immune activity of DC.
Keywords:Interleukin-18  Dendritic cells  Intervention studies
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号